The global insomnia therapeutic market size was USD 3,745 Million in 2022 and is expected to reach USD 6,885.03 Million in 2032, and register a rapid revenue CAGR of 7% during the forecast period. Increasing prevalence of insomnia among world's population as a result of lifestyle changes and rising stress are major factors driving market revenue growth. A sleep disorder called insomnia is characterized by problems getting to sleep, staying asleep, or waking up early. Insomnia may have detrimental impacts on a person's physical and mental health, increasing their likelihood of developing chronic conditions such as depression, anxiety, and hypertension.

New drug formulations have been created and sleep medicine technology has advanced, as a result of increasing need for efficient and secure treatments for insomnia. In addition, accessibility of various pharmaceutical and non-pharmacological treatment choices is also expected to drive revenue growth of the market during the forecast period. Non-pharmacological treatments, such as Cognitive-Behavioral Therapy (CBT) and relaxation techniques, are becoming more popular among patients, due to their effectiveness and safety profile.

Need for insomnia therapies is expected to rise by increasing geriatric population and prevalence of comorbidities such as Diabetes and cardiovascular disorders. It is expected that Telemedicine and Digital health technology usage will allow for Remote Patient Monitoring, individualized care, and better treatment results. Moreover, availability of wearable technology and smartphone apps for tracking sleep patterns and providing feedback to patients and healthcare professionals are other factors driving market revenue growth.

Request a sample report of Insomnia Therapeutic Market @

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

  • Sanofi S.A.
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Eisai Co., Ltd.
  • Purdue Pharma L.P.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Astellas Pharma Inc.
  • Sunovion Pharmaceuticals Inc.

Segments Covered in the Report:

By Treatment Type Outlook  
  • Prescription Drugs
  • Over-the-Counter (OTC) Medications
  • Medical Devices
  • Others
By Application Outlook  
  • Transient Insomnia
  • Short-term Insomnia
  • Chronic Insomnia

Read the full report @

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Insomnia Therapeutic industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Insomnia Therapeutic manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Explore additional Reports:

Mice Model Market @

Microcarrier Market @

Human Liver Models Market @

Clinical Laboratory Tests Market @

Lung In Vitro Model Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370


Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @

Comments (0)
No login
Login or register to post your comment